New resistance mechanism to chemotherapy in breast and ovarian cancer
Tuesday, June 18, 2013 - 14:00
in Health & Medicine
A new study explains why tumors with BRCA1 and BRCA2 mutations stop responding to PARP inhibitor drugs.
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via